Myasthenia gravis (MG) results from autoimmune antibodies against the post-synaptic neuromuscular junction with three major antibody categories: those to the acetylcholine receptor (AChR ...

Myasthenia Gravis Foundation of America (MGFA™), the largest, leading patient advocacy organization in the United States solely dedicated to the myasthenia gravis (MG) community, announced the ...

The FDA has approved Johnson & Johnson's anti-FcRn antibody, nipocalimab, for the treatment of generalized myasthenia gravis. The drug will be sold under the brand name IMAAVY. This approval ...

Myasthenia Gravis is a rare disease characterized by the gradual weakening of muscle strength. Myasthenia Gravis occurs when there are excessively high levels of antibodies in the body.

People who suffer from the autoimmune disease myasthenia gravis experience muscle weakness that can affect any of the muscles we use to blink, smile or even move our body around.

Myasthenia gravis (MG) is an autoimmune disorder that affects how well your nerves and muscles communicate. Learn more about MG symptoms.

The FDA has approved Soliris, the first-ever treatment for children with generalized myasthenia gravis (gMG), offering new hope in pediatric neuromuscular care. Learn more!

The FDA approved Soliris for children aged 6 and older with generalized myasthenia gravis (gMG), offering new hope for managing this autoimmune neuromuscular disorder.

Myasthenia gravis is a neuromuscular junction disorder with a hallmark of progressive muscle weakness and frequent manifestation of otolaryngologic dysfunction, such as difficulty swallowing and ...

Anti-acetylcholine receptor antibody (AChR-Ab) titers and the AChR-Ab rates of change correlated with myasthenia gravis disease severity scores in a recent study.

Myasthenia gravis is a chronic condition that causes your muscles to weaken quickly. Get the facts on the disease and how treatment with medications or surgery may help.

Treatment for myasthenia gravis includes medications such as pyridostigmine and immunosuppressants. Avoiding triggers may also help. Learn more here.